Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Invested Capital (2023 - 2025)

Historic Return on Invested Capital for Aytu Biopharma (AYTU) over the last 8 years, with Q4 2025 value amounting to 0.29%.

  • Aytu Biopharma's Return on Invested Capital rose 400.0% to 0.29% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.29%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.28% for FY2025, which is 2100.0% down from last year.
  • Aytu Biopharma's Return on Invested Capital amounted to 0.29% in Q4 2025, which was up 400.0% from 0.26% recorded in Q3 2025.
  • Over the past 5 years, Aytu Biopharma's Return on Invested Capital peaked at 0.02% during Q1 2024, and registered a low of 1.6% during Q2 2022.
  • In the last 5 years, Aytu Biopharma's Return on Invested Capital had a median value of 0.31% in 2024 and averaged 0.48%.
  • In the last 5 years, Aytu Biopharma's Return on Invested Capital tumbled by -5600bps in 2022 and then skyrocketed by 12500bps in 2023.
  • Quarter analysis of 5 years shows Aytu Biopharma's Return on Invested Capital stood at 0.71% in 2021, then crashed by -79bps to 1.27% in 2022, then soared by 87bps to 0.16% in 2023, then crashed by -107bps to 0.33% in 2024, then grew by 12bps to 0.29% in 2025.
  • Its Return on Invested Capital stands at 0.29% for Q4 2025, versus 0.26% for Q3 2025 and 0.22% for Q2 2025.